Evidence map›Paper›PMID 36646497›Full record

ArticleClinical endoscopy2023

Role of interventional endoscopic ultrasound in a developing country.

Hasan Maulahela, Nagita Gianty Annisa, Achmad Fauzi, Kaka Renaldi, Murdani Abdullah, Marcellus Simadibrata, Dadang Makmun, Ari Fahrial Syam

Open access · goldAbstract read
In one paragraph

Article in Clinical endoscopy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hasan MaulahelaDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Nagita Gianty AnnisaDepartment of Internal Medicine, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia.
Achmad FauziDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Kaka RenaldiDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Murdani AbdullahDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Marcellus SimadibrataDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Dadang MakmunDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
Ari Fahrial SyamDivision of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Indonesia-Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia.
University of Indonesia · ID

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsEndoscopic ultrasound (EUS) has become an essential diagnostic and therapeutic tool. EUS was introduced in 2013 in Indonesia and is considered relatively new. This study aimed to describe the current role of interventional EUS at our hospital as a part of the Indonesian tertiary health center experience.

methodsThis retrospective study included all patients who underwent interventional EUS (n=94) at our center between January 2015 and December 2020. Patient characteristics, technical success, clinical success, and adverse events associated with each type of interventional EUS procedure were evaluated.

resultsAltogether, 94 interventional EUS procedures were performed at our center between 2015 and 2020 including 75 cases of EUS-guided biliary drainage (EUS-BD), 14 cases of EUS-guided pancreatic fluid drainage, and five cases of EUS-guided celiac plexus neurolysis. The technical and clinical success rates of EUS-BD were 98.6% and 52%, respectively. The technical success rate was 100% for both EUS-guided pancreatic fluid drainage and EUS-guided celiac plexus neurolysis. The adverse event rates were 10.6% and 7.1% for EUS-BD and EUS-guided pancreatic fluid drainage, respectively.

conclusionEUS is an effective and safe tool for the treatment of gastrointestinal and biliary diseases. It has a low rate of adverse events, even in developing countries.

Indexed as

DrainageEndoscopic ultrasound-guided fine needle aspirationEndosonographyGastrointestinal endosocopy

Identifiers

PMID36646497
PMCPMC9902691
OpenAlexW4316653911

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.